These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 36051754)
1. Investigation of a combination therapy approach for the treatment of melioidosis. Barnes KB; Richards MI; Burgess G; Armstrong SJ; Bentley C; Maishman TC; Laws TR; Nelson M; Harding SV Front Microbiol; 2022; 13():934312. PubMed ID: 36051754 [TBL] [Abstract][Full Text] [Related]
2. Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei. Barnes KB; Hamblin KA; Richards MI; Laws TR; Vente A; Atkins HS; Harding SV Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438936 [No Abstract] [Full Text] [Related]
3. Layering vaccination with antibiotic therapy results in protection and clearance of Barnes KB; Brett P; Burtnick M; Vente A; Bentley C; Richards MI; Flick-Smith HC; Burgess G; Thwaite JE; Laws TR; Maishman TC; Nelson M; Harding SV Infect Immun; 2024 Mar; 92(3):e0045523. PubMed ID: 38289122 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of finafloxacin in a murine model of inhalational glanders. Barnes KB; Bayliss M; Davies C; Richards MI; Laws TR; Vente A; Harding SV Front Microbiol; 2022; 13():1057202. PubMed ID: 36504783 [No Abstract] [Full Text] [Related]
5. Potential of repurposing chloroquine as an adjunct therapy for melioidosis based on a murine model of Burkholderia pseudomallei infection. Ganesan N; Embi N; Hasidah MS Trop Biomed; 2020 Jun; 37(2):303-317. PubMed ID: 33612800 [TBL] [Abstract][Full Text] [Related]
6. Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole. Sivalingam SP; Sim SH; Jasper LC; Wang D; Liu Y; Ooi EE J Antimicrob Chemother; 2008 Mar; 61(3):674-8. PubMed ID: 18192684 [TBL] [Abstract][Full Text] [Related]
7. An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational Laws TR; Barnes KB; Jenner DC; Núñez A; Richards MI; Thwaite JE; Vente A; Rushton D; Nelson M; Harding SV Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290100 [No Abstract] [Full Text] [Related]
8. Efficacy of post exposure administration of doxycycline in a murine model of inhalational melioidosis. Gelhaus HC; Anderson MS; Fisher DA; Flavin MT; Xu ZQ; Sanford DC Sci Rep; 2013; 3():1146. PubMed ID: 23359492 [TBL] [Abstract][Full Text] [Related]
9. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders. Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435 [TBL] [Abstract][Full Text] [Related]
10. The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Barnes KB; Hamblin KA; Richards MI; Laws TR; Vente A; Atkins HS; Harding SV Front Microbiol; 2019; 10():904. PubMed ID: 31118924 [TBL] [Abstract][Full Text] [Related]
11. Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection. Barnes KB; Richards MI; Laws TR; Núñez A; Thwaite JE; Bentley C; Harding SV Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33753342 [TBL] [Abstract][Full Text] [Related]
12. In-Vitro Activity of Doxycycline and β-Lactam Combinations Against Different Strains of Mohamad NI; Harun A; Hasan H; Deris ZZ Indian J Microbiol; 2018 Jun; 58(2):244-247. PubMed ID: 29651186 [TBL] [Abstract][Full Text] [Related]
13. Assessment of CD200R Activation in Combination with Doxycycline in a Model of Melioidosis. Thom RE; Williamson ED; Casulli J; Butcher WA; Burgess G; Laws TR; Huxley P; Ashfield R; Travis MA; D'Elia RV Microbiol Spectr; 2023 Jun; 11(3):e0401622. PubMed ID: 37199641 [TBL] [Abstract][Full Text] [Related]
14. Influence of pH on the activity of finafloxacin against extracellular and intracellular Burkholderia thailandensis, Yersinia pseudotuberculosis and Francisella philomiragia and on its cellular pharmacokinetics in THP-1 monocytes. Chalhoub H; Harding SV; Tulkens PM; Van Bambeke F Clin Microbiol Infect; 2020 Sep; 26(9):1254.e1-1254.e8. PubMed ID: 31404671 [TBL] [Abstract][Full Text] [Related]
15. Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever. Hartley MG; Norville IH; Richards MI; Barnes KB; Bewley KR; Vipond J; Rayner E; Vente A; Armstrong SJ; Harding SV Front Microbiol; 2021; 12():760698. PubMed ID: 34917048 [TBL] [Abstract][Full Text] [Related]
16. Combination antimicrobial therapy of acute Burkholderia pseudomallei infection in a mouse model. Ulett GC; Norton RE; Hirst RG Pathology; 1999 Aug; 31(3):264-7. PubMed ID: 10503275 [TBL] [Abstract][Full Text] [Related]
17. Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei. Webb JR; Price EP; Currie BJ; Sarovich DS Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348161 [TBL] [Abstract][Full Text] [Related]
18. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method. Maloney S; Engler C; Norton R J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203 [TBL] [Abstract][Full Text] [Related]
19. Exploitation of the bilosome platform technology to formulate antibiotics and enhance efficacy of melioidosis treatments. D'Elia RV; Woods S; Butcher W; McGahon J; Khadke S; Perrie Y; Williamson ED; Roberts CW J Control Release; 2019 Mar; 298():202-212. PubMed ID: 30731152 [TBL] [Abstract][Full Text] [Related]